HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LNSR
LENSAR, Inc.
There isn't enough reported data to score LNSR yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LNSR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Unavailable | |
| Strong |
LNSR's revenue and balance sheet are currently healthy, but its profitability is under pressure. There isn't enough data to rate its cash flow.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LNSR PE Valuation
LNSR has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
HIMS has the edge over LNSR on the outlook, with more favorable profitability expectations.
LNSR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect LNSR's losses to grow, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
LNSR has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus LNSR down 205%.
LNSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$2.87 | -$0.14 |
| Q3 2025 | -$4.40 | -$2.96 |
| Q2 2025 | -$4.22 | -$2.68 |
| Q1 2025 | -$4.86 | -$3.30 |
| Q4 2024 | -$2.73 | -$0.96 |
| Q3 2024 | -$1.44 | +$0.23 |
| Q2 2024 | -$1.54 | +$0.29 |
| Q1 2024 | -$1.56 | +$0.13 |
LNSR lost $2.87 per share over the past year, about the same as its loss the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over LNSR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over LNSR on profitability, with a higher operating margin.
LNSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.1M | -1.3% |
| Q2 2026 | $16.5M | +18% |
| Q1 2026 | $13.4M | -5.2% |
| Q4 2025 | $16M | -4.2% |
| Q3 2025 | $14.3M | +5.7% |
| Q2 2025 | $13.9M | +10% |
| Q1 2025 | $14.2M | +34% |
| Q4 2024 | $16.7M | +38% |
LNSR's revenue fell from its 2024 peak and has held roughly level since: $14M last quarter, down 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +43 points |
| Q2 2026 | 13% | +58 points |
| Q1 2026 | 17% | +58 points |
| Q4 2025 | -31% | -23 points |
| Q3 2025 | -53% | -44 points |
| Q2 2025 | -45% | -3.3 points |
| Q1 2025 | -41% | -14 points |
| Q4 2024 | -7.7% | +17 points |
LNSR's operating margin was −10% last quarter, up 43 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
LNSR has the stronger cash trend. Its trailing FCF is up 22% versus its history, compared with HIMS at down 84%.
LNSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$978K | +$2.5M |
| Q4 2025 | $618K | -83% |
| Q3 2025 | -$3.5M | -212% |
| Q2 2025 | -$5.1M | -$1.2M |
| Q1 2025 | -$6.9M | -$1.6M |
| Q4 2024 | $3.7M | +$4.2M |
| Q3 2024 | $3.1M | +$3.5M |
| Q2 2024 | -$3.9M | -$1.6M |
LNSR has burned cash in almost every quarter: −$9M over the past year, against −$4M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LNSR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LNSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -46% | -10.6M shares |
| 1 year | +3.9% | +461K shares |
| 3 years | +15% | +1.6M shares |
| 5 years | +33% | +3.1M shares |
| Available history | +17% | +1.8M shares |
LNSR has 12M diluted shares, up 3.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LNSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.3x | Net Cash |
LNSR has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LNSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.2 | Neutral |
| Stochastic | 12.6 | Oversold |
LNSR's weekly RSI is 34 (neutral) and its Stochastic is 13 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LNSR PE vs Healthcare Sector
LNSR has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LNSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.99 | 22% below |
| 20 week MA | $6.56 | 28% below |
| 50 week MA | $7.88 | 40% below |
| 100 week MA | $10.0 | 53% below |
| 200 week MA | $6.92 | 32% below |
LNSR is in a downtrend: it's below all five of its weekly moving averages, and 32% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over LNSR on returns for 2026, with the stronger performance.
LNSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.00 | $6.86 | -24% |
| 2021 | $6.86 | $6.00 | -13% |
| 2022 | $6.00 | $2.77 | -54% |
| 2023 | $2.77 | $3.51 | +27% |
| 2024 | $3.51 | $8.38 | +139% |
| 2025 | $8.38 | $12.0 | +43% |
| 2026 YTD | $12.0 | $4.70 | -61% |
LNSR's yearly returns have swung widely, from +139% in 2024 to −54% in 2022. It's down 61% so far in 2026.